Xcout IntelPthera, LLC competitors & alternatives
The 12 closest competitors and alternatives to Pthera, LLC among medical devices companies — ranked by similarity to what Pthera, LLC actually does, not by market-cap band.
Subscribe to see Pthera, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pthera, LLC
NeuroThera develops a clinical-grade transcranial photobiomodulation platform that delivers near-infrared laser light to targeted brain regions. The company's non-invasive technology aims to treat major neurological and psychiatric conditions, including major depressive disorder, Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke recovery.
Pthera, LLC at a glance
Pthera, LLC is a medical devices company headquartered in United States. Its most recent funding round raised $400,000 in February 2016. Xcout tracks 8 named people at Pthera, LLC, including Paul Nielsen (Chief Executive Officer).
Pthera, LLC leadership
- Paul NielsenChief Executive Officer
- Dallas C. HackChief Scientific Officer
- Rhonda Robinson BealeChief Medical Officer
- Luis De TaboadaCTO & Co-Founder
- Brian PryorCo-Founder & Director
- Sean WangCo-Founder & Director
2 more named people on record for Pthera, LLC, with roles, board committees and tenure — see the full roster →
Pthera, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $400,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Pthera, LLC competitors
Ranked by semantic similarity — how close each company is to Pthera, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
NeuroGlove, LLC develops a novel medical device designed to treat a variety of neurological and psychological conditions, including stroke, Parkinson's disease, PTSD, traumatic brain injury, anxiety, depression, and insomnia. The company serves patients and healthcare sectors by providing innovative treatment options aimed at transforming healthcare.
Medical Device
NeuroEM Therapeutics develops non-invasive medical technology to treat Alzheimer's disease. The company utilizes Transcranial Electromagnetic Treatment with Radio Frequencies (TEMT-RF) to target toxic brain proteins associated with cognitive decline in patients.
Therapeutic Devices
LumiThera, Inc. is an ophthalmic medical device company that harnesses the power of light to offer a comprehensive approach for detecting and treating eye conditions.
Similar medical devices company
NeuroStar provides advanced, non-invasive transcranial magnetic stimulation (TMS) treatments designed for patients suffering from depression. The company is headquartered in Malvern, Pennsylvania, and offers physician-recommended in-office therapy.
Similar medical devices company
Nocira, LLC is a pre-market medical device company developing an investigational treatment for migraine sufferers. Its non-invasive device delivers controlled pulses of air into the ear via a mobile app to stimulate sensory neurons and reset pain mechanisms in the brain.
Similar medical devices company
Syqe Medical is a pharma-tech company that develops a precision inhalation platform designed to deliver central nervous system (CNS) drugs with pharmaceutical-grade accuracy. The company's technology features micro-dosing capabilities, consistent absorption technologies, and cloud-connected adherence tracking to optimize treatments for conditions such as diabetic peripheral neuropathic pain, PTSD, and insomnia.
Similar medical devices company
Luminopia, Inc. is a commercial-stage company based in Cambridge, Massachusetts, that pioneered and develops a new class of treatments for neuro-visual conditions.
Similar medical devices company
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Similar medical devices company
BIOflex Technologies Inc designs and manufactures non-invasive therapeutic laser and electrotherapeutic systems utilizing photobiomodulation technology. The company provides professional-grade and personal-use devices, such as multi-port systems and pet therapy solutions, aimed at accelerating recovery, reducing pain, and promoting cellular regeneration for clinics and home users.
Therapeutic Devices
Sonomind is a medical device company specializing in non-invasive brain stimulation utilizing low-intensity focused ultrasound to treat drug-resistant conditions. The Paris-based biotech and life science startup develops novel neurostimulation therapies and recently secured funding to advance its medical technology.
Similar medical devices company
Blackrock Neurotech develops innovative brain-computer interface technologies designed to restore function, communication, and movement for individuals with paralysis and neurological disorders.
Similar medical devices company
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pthera, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pthera, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →